Monopar Therapeutics
MNPR
MNPR
43 hedge funds and large institutions have $113M invested in Monopar Therapeutics in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 15 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% more capital invested
Capital invested by funds: $109M → $113M (+$3.93M)
Holders
43
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.82M | |
| 2 | +$1.73M | |
| 3 | +$1.35M | |
| 4 |
ABG
Ally Bridge Group
New York
|
+$1.24M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.12M |
Top Sellers
| 1 | -$2.29M | |
| 2 | -$1.63M | |
| 3 | -$946K | |
| 4 |
Goldman Sachs
New York
|
-$673K |
| 5 |
Jane Street
New York
|
-$377K |
